We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
Cap. Flow
-$49.9M
Cap. Flow %
-1.98%
Top 10 Hldgs %
37.25%
Holding
3,473
New
219
Increased
908
Reduced
1,468
Closed
292

Top Buys

Rank Stock Value
1
FALN icon
iShares Fallen Angels USD Bond ETF
FALN
+$9.31M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$6.87M
3
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
+$3.6M
4
CORT icon
Corcept Therapeutics
CORT
+$3M
5
SPSB icon
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
+$2.68M

Top Sells

Rank Stock Value
1
ESGV icon
Vanguard ESG US Stock ETF
ESGV
+$9.63M
2
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$7.01M
3
MSFT icon
Microsoft
MSFT
+$5.41M
4
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$5.16M
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$4.44M

Sector Composition

Rank Sector Weight
1 Technology 15.38%
2 Financials 8.17%
3 Healthcare 7.07%
4 Consumer Discretionary 4.99%
5 Communication Services 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMCSA icon
126
Comcast
CMCSA
$90B
$2.88M 0.11%
60,415
+2,508
+4% +$121K
RCUS icon
127
Arcus Biosciences
RCUS
$3.64B
$2.83M 0.11%
84,828
+25
+0% +$838
SNOW icon
128
Snowflake
SNOW
$115B
$2.79M 0.11%
12,041
-4,813
-29% -$1.24M
AMT icon
129
American Tower
AMT
$80.4B
$2.76M 0.11%
11,016
+237
+2% +$57.8K
EFTR
130
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$2.74M 0.11%
+27,098
New +$3.6M
HDV
131
iShares Core High Dividend ETF
HDV
$14.9B
$2.72M 0.11%
125,940
+1,470
+1% +$30.5K
VTIP icon
132
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$2.7M 0.11%
52,599
+13,939
+36% +$715K
LYFT icon
133
Lyft
LYFT
$6.63B
$2.7M 0.11%
69,859
+109
+0.2% +$4.27K
BRK.A icon
134
Berkshire Hathaway Class A
BRK.A
$1.12T
$2.68M 0.11%
5
– –
CVS icon
135
CVS Health
CVS
$122B
$2.67M 0.11%
25,757
-14,961
-37% -$1.57M
SBUX icon
136
Starbucks
SBUX
$120B
$2.62M 0.1%
28,764
-1,877
-6% -$177K
MGC icon
137
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
$2.6M 0.1%
16,116
-3,646
-18% -$572K
TSM icon
138
TSMC
TSM
$2.18T
$2.58M 0.1%
24,145
-3,319
-12% -$388K
LQD icon
139
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
$2.57M 0.1%
21,167
-4,148
-16% -$517K
MCD icon
140
McDonald's
MCD
$195B
$2.55M 0.1%
10,229
-1,030
-9% -$257K
HON icon
141
Honeywell
HON
$78B
$2.52M 0.1%
13,614
+663
+5% +$123K
ARKK icon
142
ARK Innovation ETF
ARKK
$6.31B
$2.5M 0.1%
36,401
-991
-3% -$69.9K
ADI icon
143
Analog Devices
ADI
$190B
$2.48M 0.1%
14,908
+7,424
+99% +$1.2M
VT icon
144
Vanguard Total World Stock ETF
VT
$79.8B
$2.46M 0.1%
23,897
+100
+0.4% +$10.1K
BND icon
145
Vanguard Total Bond Market
BND
$158B
$2.44M 0.1%
30,676
-33,631
-52% -$2.75M
AVGO icon
146
Broadcom
AVGO
$2.04T
$2.4M 0.1%
38,080
-570
-1% -$33.9K
TGT icon
147
Target
TGT
$68B
$2.39M 0.09%
10,775
+530
+5% +$115K
IVW icon
148
iShares S&P 500 Growth ETF
IVW
$77.6B
$2.34M 0.09%
30,067
+3,434
+13% +$258K
VCSH icon
149
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$2.33M 0.09%
29,910
-3,469
-10% -$276K
FCX icon
150
Freeport-McMoran
FCX
$97.5B
$2.33M 0.09%
45,956
-1,149
-2% -$50.9K
4 5
6
7 8

Similar funds

HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Parallel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q1 2022 filing shows 219 new, 908 increased, 1,468 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
  • Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
  • Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
  • Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
  • Parallel Advisors opened 219 new positions and closed 292 in Q1 2022.
  • Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.